BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes ; volume:7 ; number:1 ; day:21 ; month:11 ; year:2019 ; pages:1-14 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (21.11.2019), 1-14, 12.2019
- Creator
-
Chen, Yu-Li
Lin, Han-Wei
Chien, Chung-Liang
Lai, Yen-Ling
Sun, Wei-Zen
Chen, Chi-An
Cheng, Wen-Fang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0744-4
- URN
-
urn:nbn:de:101:1-2020031720281343596142
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Yu-Li
- Lin, Han-Wei
- Chien, Chung-Liang
- Lai, Yen-Ling
- Sun, Wei-Zen
- Chen, Chi-An
- Cheng, Wen-Fang
- SpringerLink (Online service)
Other Objects (12)
Mannan-induced Nos2 in macrophages enhances IL-17–driven psoriatic arthritis by innate lymphocytes
NLRP3 ablation enhances tolerance in heat stroke pathology by inhibiting IL-1β-mediated neuroinflammation
IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
IL-2 and IL-15 dependent thymic development of Foxp3-expressing regulatory T lymphocytes
Correction to: IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
Sphingosine Kinases promote IL-17 expression in human T lymphocytes
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms
Peripheral human CD4+CD8+ T lymphocytes exhibit a memory phenotype and enhanced responses to IL-2, IL-7 and IL-15
IL-25 blockade inhibits metastasis in breast cancer
Inhibiting IL-6 in COVID-19: we are not sure
Systemische JIA – Reversion der Neutrophilreaktion durch IL-1-Blockade
Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy
Mannan-induced Nos2 in macrophages enhances IL-17–driven psoriatic arthritis by innate lymphocytes
NLRP3 ablation enhances tolerance in heat stroke pathology by inhibiting IL-1β-mediated neuroinflammation
IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
IL-2 and IL-15 dependent thymic development of Foxp3-expressing regulatory T lymphocytes
Correction to: IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
Sphingosine Kinases promote IL-17 expression in human T lymphocytes
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms
Peripheral human CD4+CD8+ T lymphocytes exhibit a memory phenotype and enhanced responses to IL-2, IL-7 and IL-15
IL-25 blockade inhibits metastasis in breast cancer
Inhibiting IL-6 in COVID-19: we are not sure
Systemische JIA – Reversion der Neutrophilreaktion durch IL-1-Blockade
Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy
Mannan-induced Nos2 in macrophages enhances IL-17–driven psoriatic arthritis by innate lymphocytes
NLRP3 ablation enhances tolerance in heat stroke pathology by inhibiting IL-1β-mediated neuroinflammation
IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
IL-2 and IL-15 dependent thymic development of Foxp3-expressing regulatory T lymphocytes
Correction to: IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
Sphingosine Kinases promote IL-17 expression in human T lymphocytes
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms
Peripheral human CD4+CD8+ T lymphocytes exhibit a memory phenotype and enhanced responses to IL-2, IL-7 and IL-15
IL-25 blockade inhibits metastasis in breast cancer
Inhibiting IL-6 in COVID-19: we are not sure
Systemische JIA – Reversion der Neutrophilreaktion durch IL-1-Blockade